Folates and cardiovascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 1, 2002, Pages 6-13

  Verhaar, Marianne C ^a   Stroes, E ^a   Rabelink, T J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular disease; Cardiovascular risk; Endothelium; Folates

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; NITRIC OXIDE SYNTHASE;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FOLIC ACID BLOOD LEVEL; HOMOCYSTINURIA; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN INTERACTION; SHORT SURVEY;

ARTERIOSCLEROSIS; BIOPTERIN; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+); NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; OXIDOREDUCTASES;

EID: 0036143349     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0102.102190     Document Type: Short Survey

References (109)

1. Synthesis of a compound identical with the L. casei factor isolated from liver
2. Folate levels and neural tube defects: Implications for prevention
3. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
4. Folate-responsive neuropathy: Report of 10 cases
5. Nutrition and depression: The role of folate
6. Folate and carcinogenesis: An integrated scheme
7. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
8. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
9. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia
10. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
11. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
12. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
13. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
14. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease
15. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
16. Folate improves endothelial function in coronary artery disease: An effect mediated by reduction of intracellular superoxide?
17. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia
18. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: Restoration by folic acid
19. Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia
20. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: A human in vivo study
21. 5-Methyltetrahydrofolate, the active form of folic acid, improves endothelial function in familial hypercholesterolemia
22. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: A randomised placebo-controlled trial
23. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
24. Influence of folic acid on postprandial endothelial dysfunction
25. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk?: Design of clinical trials to test the homocysteine hypothesis of vascular disease
26. Homocysteine and vascular disease
27. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group
28. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease
29. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene
30. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate
31. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls
32. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis
33. Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate
34. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease
35. Serum folate and cardiovascular disease mortality among US men and women
36. Serum folate and chronic disease risk: Findings from a cohort of United States adults
37. Serum folate and risk for ischemic stroke: First National Health and Nutrition Examination Survey epidemiologic follow-up study
38. Low serum folate concentrations are associated with an excess incidence of acute coronary events: The Kuopio Ischaemic Heart Disease Risk Factor Study
39. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
40. Serum folate and risk of fatal coronary heart disease
41. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians
42. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study
43. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women
44. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study
45. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
46. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease
47. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
48. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
49. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation
50. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
51. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
52. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
53. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: A case-control study
54. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: Results among U.S. men
55. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction
56. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
57. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
58. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates-implications for folate intake recommendations
59. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial
60. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
61. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual?
62. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association
63. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
64. Homocysteine and atherothrombosis
65. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy
66. Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans
67. Oxidative stress and cardiovascular disease
68. Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
69. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
70. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
71. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolaemia
72. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients
73. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipopruteins levels
74. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease
75. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation
76. Folic acid reverts dysfunction of endothelial nitric oxide synthase
77. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids
78. Vitamins C, E and A and heme oxygenase in rats fed methyl/folate-deficient diets
79. Nitric oxide synthase: Aspects concerning structure and catalysis
80. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process
81. Origin of superoxide production by endothelial nitric oxide synthase
82. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
83. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
84. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia
85. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin
86. A synthetic peptide corresponding to the putative dihydrofolate reductase domain of nitric oxide synthase inhibits uncoupled NADPH oxidation
87. Folate and nitrate-induced endothelial dysfunction: A simple treatment for a complex pathobiology
88. L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin
89. Some metabolic relationships between biopterin and folate: Implications for the "methyl trap hypothesis."
90. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency
91. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
92. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
93. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy
94. Does folic acid decrease plasma homocysteine and improve endothelial function in patient with predialysis renal failure?
95. Effect of a single high-fat meal on endothelial function in healthy subjects
96. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects
97. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
98. Vegetable consumption and risk of chronic disease
99. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: Results of one year follow up
100. Fruit and vegetable intake in relation to risk of ischemic stroke
101. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group
102. Trends in serum folate after food fortification
103. Prevention of neural-tube defects
104. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
105. Plasma and red blood cell folate during normal pregnancies
106. Cleavage of folates during ethanol metabolism
107. How safe are folic acid supplements?
108. Prevalence of cobalamin deficiency in the Framingham elderly population
109. Megaloblastic anaemia in a vegetarian Hindu community